Brief: Virpax Pharmaceuticals Reports Q2 Results, Recent Developments
15/08/2022 14:15
Aug 15 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS REPORTS 2022 SECOND QUARTER RESULTS
AND
RECENT DEVELOPMENTS
* VIRPAX PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.50
Source text for Eikon: ID:nBw9y8hsNa
Further company coverage: VRPX.O
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study